Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
×
May 11, 2023 · NAFLDkb integrates various aspects of DDAs from curated data including drug-target, drug-strategy, drug-clinical trial, drug-gene expression ...
Here, we present NAFLDkb, a specialized knowledge base and platform for computer-aided drug design against NAFLD. With multiperspective information curated from ...
NAFLDkb: a knowledge base and platform for drug development against non-alcoholic fatty liver disease.
NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease ... platform for computer-aided drug design against NAFLD ...
May 17, 2024 · NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease ... Nonalcoholic Fatty Liver Disease ...
People also ask
NAFLD consists of nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). NAFL is characterized by hepatic steatosis without hepatocyte ...
People also search for
Related conditions
For informational purposes only. Consult your local medical authority for advice.
Non-alcoholic fatty liver disease (NAFLD) is a major public health issue worldwide. It is the most common liver disease in Western countries, andits global ...
In this study, we applied a network-based framework for comprehensively identifying candidate flavonoids for the prevention and/or treatment of NAFLD. Flavonoid ...